TITLE:
Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia

CONDITION:
Pneumonia

INTERVENTION:
Tifacogin

SUMMARY:

      The purpose of this study is to determine whether tifacogin is effective and safe in the
      treatment of patients with severe community-acquired pneumonia.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: N/A to N/A
Criteria:

        Inclusion Criteria:

          -  Diagnosis of community-acquired pneumonia supported by additional clinical,
             radiological, and microbiological evidence

          -  Pneumonia of sufficient severity to require ICU admission and management

        Exclusion Criteria:

          -  Pregnancy

          -  Weight over 150 kg

          -  Patients at increased risk of bleeding

          -  Treatment with drotrecogin alfa or anticipated need for drotrecogin alfa

          -  Treatment with heparin or anticipated need for heparin
      
